Cargando…
Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer
BACKGROUND: The pancreatic cancer vaccine, GVAX, induces novel lymphoid aggregates in the otherwise immune quiescent pancreatic ductal adenocarcinoma (PDAC). GVAX also upregulates the PD-1/PD-L1 pathway, and a pre-clinical model demonstrated the anti-tumor effects of combination GVAX and anti-PD-1 a...
Autores principales: | Saung, May Tun, Muth, Stephen, Ding, Ding, Thomas, Dwayne L., Blair, Alex B., Tsujikawa, Takahiro, Coussens, Lisa, Jaffee, Elizabeth M., Zheng, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234697/ https://www.ncbi.nlm.nih.gov/pubmed/30424804 http://dx.doi.org/10.1186/s40425-018-0435-6 |
Ejemplares similares
-
Regulation of Granulocyte and Macrophage Populations of Murine Bone Marrow Cells by G-CSF and CD137 Protein
por: Jiang, Dongsheng, et al.
Publicado: (2010) -
CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma
por: Wang, Jianxin, et al.
Publicado: (2022) -
Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape
por: Osipov, Arsen, et al.
Publicado: (2019) -
Effect of genetic SSTR4 ablation on inflammatory peptide and receptor expression in the non-inflamed and inflamed murine intestine
por: Van Op den bosch, Joeri, et al.
Publicado: (2009) -
Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibitors in treating pancreatic cancer
por: Fujiwara, Kenji, et al.
Publicado: (2020)